Facebook
Twitter
LinkedIn
ForwardThe First Annual Houston "Prevention Rules for Cardiometabolic Diseases"
Virtual Conference
Saturday, September 19, 2020
Activity Overview
Cardiovascular disease remains the leading cause of death in the United States despite a significant decrease in the morbidity and mortality associated with the disease. Clinical practice and research efforts have placed emphasis on the treatment of cardiovascular disease rather than on the prevention of events. There is a critical need to transition focus from interventional strategies to the prevention of cardiovascular disease, particularly in light of the rapid rise in patients with obesity and diabetes. This educational event aims to provide physicians, fellows, residents, students and other health care professionals with the knowledge and skills in the management of hypercholesterolemia, hypertension and diabetes in the treatment of cardiometabolic disease and prevention of cardiovascular diseases that can be incorporated it into clinical practice.
Target Audience
This course is designed for primary care providers (internal medicine, family practice), cardiologists, allied health professionals (nurse practitioners, physician assistants, pharmacists), and endocrinologists.
Learning Objectives
At the conclusion of the conference, participants should be able to:
- Implement the new guidelines related to cardiovascular disease risk prediction and management of lipid abnormalities, diabetes and hypertension
- Outline the advances and guidelines in the management of lipid (cholesterol) related abnormalities and list therapies int he horizon
- Discuss recent advances in the management of diabetes mellitus, and the available options for the medical management of diabetes mellitus with a specific focus on their cardiovascular benefit and outline the therapies on the horizon
- Summarize the current clinical approach towards the management of hypertension and identify patients in whom intensive blood pressure management could be pursued
Educational Methods
Lectures ▪ Panel Discussion ▪ Question and Answer Sessions
Activity Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.
Additional Information
| Attachment | Size |
|---|---|
 1653 - Brochure 20200908.pdf | 880.74 KB |
SATURDAY, SEPTEMBER 19, 2020 | ||
7:45 AM | Welcome | |
CONTEMPORARY MANAGEMENT OF DYSLIPIDEMIA | ||
8:00 | The Lipid Guideline Approach Towards Primary and Secondary Prevention | Salim Virani, M.D., Ph.D. |
8:30 | Imaging to Assess Cardiovascular Disease Risk | Khurram Nasir, M.D. |
8:50 | Statin Intolerance: Definition and Approaches | Vijay Nambi, M.D., Ph.D. |
9:10 | A Deep Dive into Management of Hypertriglyceridemia | Peter Jones, M.D. |
9:30 | PCKS9 – Inhibitors | Pam Taub, M.D. |
9:50 | Lipoprotein (a) and novel biologics: The Next Frontiers in Lipid Management | Christie Ballantyne, M.D. |
10:15 | Panel Discussion | |
10:45 | Break | |
LIFESTYLE CHOICES, CHALLENGES, AND GUIDELINES | ||
11:00 | Weight Loss – Tips, Tricks, and Recommendations | Peter Jones, M.D. |
11:30 | Physical Activity – Recommendations and How to Achieve | John Foreyt, M.D. |
12:00 PM | Lunch | |
CONTEMPORARY DIABETES MANAGEMENT | ||
1:00 | Diabetes Guidelines | Mandeep Bajaj, M.D. |
1:30 | Diabetes Management in Cardiovascular Disease Prevention | Robert Eckel M.D. |
2:00 | Diabetes Management in Heart Failure | David Aguilar M.D. |
2:20 | Panel Discussion | |
2:45 | Break | |
HYPERTENSION MANAGEMENT | ||
3:00 | Hypertension Guidelines | Addison Taylor, M.D., M.P.H. |
3:20 | Resistant Hypertension and the Future Landscape in the Management of Hypertension | Sandra Taler, M.D. |
3:40 | Panel Discussion | |
4:00 | Adjourn | |
Disclaimer
This activity is designed for healthcare professionals for educational purposes. Information and opinions offered by the faculty/presenters represent their own viewpoints. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information.
While Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Faculty/presenters have submitted materials for this syllabus for printing in advance so that you may have an outline or summary of the main points of their presentation. Often this differs from the final version of their slides as faculty/ presenters make revisions up until the day of the meeting.
Additionally, some images (cartoons, drawings and some photographs) shown on the screen may not be present in your educational materials because of publishers’ requirements for reprinting of copyrighted images.
Notices
Faculty, topics, program schedule, and credit are subject to change.
Audio or videotaping is prohibited without written permission from the Activity Directors and the Division of Continuing Professional Development, Baylor College of Medicine, Houston, Texas.
Conference offered virtually via Zoom.
Connection information will be emailed to registrants the week of the conference.
Physicians
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 6.75 AMA PRA Category 1 Credit™
- 6.75 Attendance